46 related articles for article (PubMed ID: 25119656)
1. Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter.
Graf H
Eur J Endocrinol; 2015 Feb; 172(2):R47-52. PubMed ID: 25189867
[TBL] [Abstract][Full Text] [Related]
2. Thyroid abnormalities.
Weetman AP
Endocrinol Metab Clin North Am; 2014 Sep; 43(3):781-90. PubMed ID: 25169567
[TBL] [Abstract][Full Text] [Related]
3. Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?
Antel J; Albayrak Ö; Heusch G; Banaschewski T; Hebebrand J
Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):233-47. PubMed ID: 25149468
[TBL] [Abstract][Full Text] [Related]
4. Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus.
Fournier JP; Yin H; Yu OH; Azoulay L
CMAJ; 2014 Oct; 186(15):1138-45. PubMed ID: 25246411
[TBL] [Abstract][Full Text] [Related]
5. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
Ghamami N; Chiang SH; Dormuth C; Wright JM
Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
[TBL] [Abstract][Full Text] [Related]
6. Is an isolated TSH elevation in chronic nonthyroidal illness "subclinical hypothyroidism"?
Kaptein EM; LoPresti JS; Kaptein MJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4015-26. PubMed ID: 25166720
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis.
Yang XP; Lai D; Zhong XY; Shen HP; Huang YL
Eur J Clin Pharmacol; 2014 Oct; 70(10):1149-58. PubMed ID: 25124541
[TBL] [Abstract][Full Text] [Related]
8. Effects of levothyroxine treatment on insulin sensitivity, endothelial function and risk factors of atherosclerosis in hypothyroid women.
Deyneli O; Akpınar IN; Meriçliler OS; Gözü H; Yıldız ME; Akalın NS
Ann Endocrinol (Paris); 2014 Sep; 75(4):220-6. PubMed ID: 25145560
[TBL] [Abstract][Full Text] [Related]
9. No improvement of high-density lipoprotein (HDL) vasorelaxant effect despite increase in HDL cholesterol concentration in type 2 diabetic patients treated with glitazones.
Perségol L; Duvillard L; Monier S; Brindisi MC; Bouillet B; Petit JM; Vergès B
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2015-9. PubMed ID: 25137425
[TBL] [Abstract][Full Text] [Related]
10. Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review.
Cavalheiro BG; Shah JP; Randolph GW; Medina JE; Tufano RP; Zafereo M; Hartl DM; Nixon IJ; Guntinas-Lichius O; Vander Poorten V; López F; Khafif AH; Owen RP; Shaha A; Rodrigo JP; Rinaldo A; Mäkitie AA; Silver CE; Sanabria A; Kowalski LP; Ferlito A
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765880
[TBL] [Abstract][Full Text] [Related]
11. Thyroglobulin-Based Risk Factor Repositioning for Determining Radioactive Iodine Activity in Patients with Papillary Thyroid Carcinoma: a Multicenter Retrospective Cohort Study.
Jeon S; Kwon SY; Lee SW; Bae SK
Nucl Med Mol Imaging; 2022 Aug; 56(4):173-180. PubMed ID: 35846420
[TBL] [Abstract][Full Text] [Related]
12. Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine.
Rosario PW; Mourão G; Calsolari MR
J Endocrinol Invest; 2019 Jun; 42(6):687-692. PubMed ID: 30353424
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b).
Rosario PW; Mourão GF; Calsolari MR
Arch Endocrinol Metab; 2017; 61(2):167-172. PubMed ID: 28226001
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radioactive iodine administration for differentiated thyroid cancer patients.
Lepoutre-Lussey C; Deandreis D; Leboulleux S; Schlumberger M
Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):363-71. PubMed ID: 25119656
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of surgical completeness in endoscopic thyroidectomy compared with open thyroidectomy with regard to remnant ablation.
Im HJ; Koo do H; Paeng JC; Lee KE; Chung YS; Lim I; Lee DS; Chung JK; Youn YK
Clin Nucl Med; 2012 Feb; 37(2):148-51. PubMed ID: 22228337
[TBL] [Abstract][Full Text] [Related]
16. Radioactive iodine therapy.
Lee SL
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):420-8. PubMed ID: 22914564
[TBL] [Abstract][Full Text] [Related]
17. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.
Wang TS; Evans DB; Fareau GG; Carroll T; Yen TW
Ann Surg Oncol; 2012 Dec; 19(13):4217-22. PubMed ID: 23010732
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine remnant ablation in low-risk differentiated thyroid cancer.
Saengsuda Y
J Med Assoc Thai; 2013 May; 96(5):614-24. PubMed ID: 23745318
[TBL] [Abstract][Full Text] [Related]
19. Postoperative management of differentiated thyroid cancer.
Sabet A; Kim M
Otolaryngol Clin North Am; 2010 Apr; 43(2):329-51, viii-ix. PubMed ID: 20510717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
